Monday, October 27, 2025
HomeNews

News

Soleo Health Prepared to Meet Increased Demand of FDA-Approved LEQEMBI™ (lecanemab-irmb) to Treat Alzheimer’s Disease

Company Provides Alzheimer’s Disease Patients Greater Access to Care through Administration of LEQEMBI In-home or On-site at its Infusion Centers Soleo Health, an innovative leader and...

SolarEdge Appoints New Director to Its Board

SolarEdge Technologies, Inc., a global leader in smart energy technology, announced the appointment of Ms. Dana Gross as a member of its Board of...

Valmont to Acquire HR Products, Australian Leader in Irrigation Parts

Valmont Industries, Inc., a global leader that provides vital infrastructure and advances agricultural productivity while driving innovation through technology, announced it has entered into...

BIOTRONIK Receives FDA Approval For Next-Generation Family of Pacemakers

The Amvia Edge pacemaker platform introduces always-on, automatic MR detection algorithm to fully streamline MRI workflow. BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval...

FDA converts approval process for new Alzheimer’s disease treatment to traditional approval

The US Food and Drug Administration (FDA) converted the approval process for Leqembi ( lecanemab-irmb), indicated for the treatment of adult patients with Alzheimer's...
0FansLike
0FollowersFollow
spot_img

Hot Topics